TW201016921A - Electrospinning compositions for the preparation of nanofibers and the applications thereof - Google Patents

Electrospinning compositions for the preparation of nanofibers and the applications thereof Download PDF

Info

Publication number
TW201016921A
TW201016921A TW97141495A TW97141495A TW201016921A TW 201016921 A TW201016921 A TW 201016921A TW 97141495 A TW97141495 A TW 97141495A TW 97141495 A TW97141495 A TW 97141495A TW 201016921 A TW201016921 A TW 201016921A
Authority
TW
Taiwan
Prior art keywords
weight
cellulose acetate
composition
solution
cellulose
Prior art date
Application number
TW97141495A
Other languages
Chinese (zh)
Other versions
TWI376440B (en
Inventor
Yu-Chun Tang
Haw-Jer Chang
Original Assignee
Taiwan Textile Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiwan Textile Res Inst filed Critical Taiwan Textile Res Inst
Priority to TW97141495A priority Critical patent/TWI376440B/en
Publication of TW201016921A publication Critical patent/TW201016921A/en
Application granted granted Critical
Publication of TWI376440B publication Critical patent/TWI376440B/en

Links

Landscapes

  • Artificial Filaments (AREA)
  • Spinning Methods And Devices For Manufacturing Artificial Fibers (AREA)

Abstract

The present invention relates to a electrospinning composition for the preparation of nanofiber films, comprising (A) a uniform solution containing a cellulose acetate and a solvent, and (B) a tetracyclic compound and the derivates thereof; to a process for the improvement of conductivity and fineness of nanofibers based on cellulose acetates, comprising the step of applying the said composition through a electrospinning device to form nanofibers having improved properties of conductivity and uniform fineness; to a nanofiber film based on cellulose acetates exhibiting, simultaneously, excellent spinnability and good anti-bacteriall effect.

Description

201016921 '、發明說明: 【發明所屬之技術領域】 及一種醋酸纖 維素奈米纖維膜材 本發明關於-種轉製造奈米纖轉材之靜 種改善醋酸齡素奈之導電度及細度之方法德成物, 【先前技射年】 ❹ 15 20201016921 ', invention description: [technical field to which the invention belongs] and a cellulose acetate nanofiber membrane material. The present invention relates to the improvement of the conductivity and fineness of the acetic acid sensitization. Method Decheng, [previous technical year] ❹ 15 20

已知,使用傳統上製備醋酸纖維素纖維(諸如 之方法通常無法觀__、於·⑽的奈=維素H 性奈米纖維—般會在奈米纖維材料中添加抗_二二 電紡絲技*孩奈米纖維的效果’特別是例如以贈酸纖维素 的奈輯維,為解決上關題,—般餘加魏高分子,例 聚%,乙烯’祕奈雜軸絲來達卿成奈雜維之效果。此 外為提而奈频料電度進而控制靜電紡絲的效果,通常會直接添 加奈米銀於溶液巾,但此結絲彳±造成驗分舰不佳或產生聚华 物,其使紡嘴堵塞而影響靜電紡絲效果。 A本 t : -Ultrafme porous fibers electrospun from cellulose triacetate", Seong Ok Han et al, Materials Letters 59 (2005), PP 2998-3001,揭示以靜電紡絲技術製備三醋酸纖維素多孔纖維, 該文獻中針對不同比例的共溶劑例如二氯甲烧/酒精(比例為%〗至 I:9)對纖、維製備效果的影響進行比較。以共溶劑製備的三醋酸纖維 素纖維,其獲得的纖維型態一般為不均勻,且細度分佈從微米至次 微米。. 4 201016921 先前技術:’’Electrospun cellulQse a_e — _aining chlorhexidine as a bactericide», Liang Chen et al, Polymer 49 (2008), ppl266· ’揭林醋酸_她環氧乙_高分子溶液中添加 抗菌劑’例如氯己定,之後進行靜電_以獲得具有抗菌功能的奈 5米纖維,然而此方式獲得的奈米纖維的可紡性並不佳,由於抗菌劑 (chlorhexidine)的添加會影響靜電紡絲醋故纖騎的效杲,—般須添 加聚環氧乙烯方可改善此問題。 ❹ 先前技術:”顧microbial cellulose acetate nan〇flbers silver nanoparticles», Won Keun Son et al, Carbohydrate Polymers 65 J〇 (2〇〇6),PP430·434 ’揭示在醋酸纖維素高分子溶液中加入碗酸銀, f断靜電_翻奈米纖賴後,翻uv麟财式提供能 置’使奈米銀於纖維中還原。此種方式雖可獲得具有抗菌功能的夺 米銀醋酸纖維素奈米纖維,但直接在高分子溶液中加入奈米銀容易 產生聚集的現象因而會影響纖維的可纺性。另一方面,於高分子溶 15 液中添加硝酸銀會形成銀離子,在靜電紡絲時不會因為粒子聚集而 ❹ 影響可紡性,在事後以照射UV的方式使銀離子還原成奈米銀了但 由於存在未還原的銀離子而可能會對細胞造成直接的傷害。在習知 的先前的技術中,為了避免奈米銀聚集而影響靜電紡絲的可紡性, 一般採用硝酸銀於高分子溶液中形成銀離子之方式,於靜電紡絲獲 20 得纖維後以照射UV光還原奈米銀的方式獲得具有抗菌效果的奈米 銀醋酸纖維素奈米纖維膜。 又,先前技術:,,Vitamin_Ioaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin EJ,, Pattama Taepaiboon et al, European Journal of 201016921It is known to use conventionally prepared cellulose acetate fibers (such as the method which is generally incapable of viewing __, (10) nai-vitamin H-nanofibers), and adding anti-two-two electrospinning to the nanofiber material. Silk technology * The effect of the child's nanofibers', especially for example, the nano-dimensional of the acid cellulose, to solve the above problem, the general balance plus Wei polymer, the example of the poly%, ethylene 'my Na miscellaneous wire The effect of Daqing Cheng Nai Weiwei. In addition, in order to control the effect of electrospinning, the nano-silver is usually added directly to the solution towel, but the knot is not good or the inspection ship is poor. Producing a merging material, which causes the spinning nozzle to clog and affects the electrospinning effect. A: t: -Ultrafme porous fibers electrospun from cellulose triacetate", Seong Ok Han et al, Materials Letters 59 (2005), PP 2998-3001, reveals The cellulose triacetate porous fiber was prepared by an electrospinning technique, and the effects of different ratios of co-solvents such as dichloromethane/alcohol (% to I:9) on the preparation of fibers and dimensions were compared. Triacetate cellulose fiber prepared by cosolvent The fiber form obtained is generally non-uniform and the fineness distribution is from micron to submicron. 4 201016921 Prior art: ''Electrospun cellulQse a_e — _aining chlorhexidine as a bactericide», Liang Chen et al, Polymer 49 (2008 ), ppl266· 'Jie Lin acetic acid _ her epoxy B _ polymer solution added antibacterial agent' such as chlorhexidine, and then static electricity _ to obtain antibacterial function of the 5 m fiber, however, the nanofiber obtained in this way The spinnability is not good, because the addition of chlorhexidine will affect the effect of electrospinning vinegar, it is necessary to add polyethylene oxide to improve this problem. 先前 Previous technology: "Gu microbial Cellulose acetate nan〇flbers silver nanoparticles», Won Keun Son et al, Carbohydrate Polymers 65 J〇(2〇〇6), PP430·434 'disclosed to the addition of bowl of silver acetate in the cellulose acetate polymer solution, f broken static _ turn After the nano-fiber ray, the uv lining finance provides the ability to set the nano silver to be reduced in the fiber. In this way, the rice-silver cellulose acetate nanofiber with antibacterial function can be obtained. However, the addition of nano silver directly to the polymer solution tends to cause aggregation, which affects the spinnability of the fiber. On the other hand, the addition of silver nitrate to the polymer solution 15 forms silver ions, which does not occur during electrospinning. Because the particles aggregate and ❹ affects the spinnability, the silver ions are reduced to nano silver by UV irradiation afterwards, but direct damage to the cells may occur due to the presence of unreduced silver ions. In the prior art, in order to avoid the influence of nano-silver aggregation on the spinnability of electrospinning, silver nitrate is generally used to form silver ions in a polymer solution, and 20 fibers are obtained by electrospinning to irradiate A nanosilver cellulose acetate nanofiber membrane having an antibacterial effect is obtained by UV light reduction of nano silver. Further, prior art:, Vitamin_Ioaded electrospun cellulose acetate nanofiber mats as transdermal and dermal therapeutic agents of vitamin A acid and vitamin EJ,, Pattama Taepaiboon et al, European Journal of 201016921

Pharmaceutics and Biopharmaceutics 67 (2007),pp387-397,揭示在醋 酸纖維素溶液中加入維生素A酸及維生素E,及以靜電紡絲方式製 成奈米纖維薄膜,該薄膜可用於藥物釋放之用途。基本上,添加5重 量%的維生素A酸/維生素E於高分子溶液中,對控制醋酸纖維素 5 的細度並沒有幫助。 為了改善先前技術中因為加入(例如)奈米銀等類的添加物而產 生聚集的問題及影響纖維的可纺性,本發明提供一種含有四賴素 參化合物的靜電紡絲組成物,用以改善醋酸纖維素高分子溶液的導電 度’及同時控制纖維直徑而獲得直徑較細錢維蠢更為均一的太 j。米纖維膜。本發明又提供一種可降低奈米纖維粒徑之方法,= . 善醋酸纖維素之靜電紡絲效果。 【發明内容】 參 本發明之-目的在於提供—_於製絲米_騎之靜 絲組成物’其特徵在於使用四魏素化合恤維素 溶液的導電度,其中該組成物包含: “ A) 含有醋酸纖維素與溶劑之均句溶液,其中,以溶 準,該醋酸纖維素的含量為〇〇1 置马暴 包含三氣甲r1㈣ 及該溶劑選自群組 兀一、甲、元、一甲基亞颯、二甲基甲醯胺、乙醇、四 虱呋喃、醋酸及丙酮或上述至少二者的組合, B) 以上述均勻溶液的重量為基準,〇 〇1至l 素化合物及其衍生物, 20 201016921Pharmaceutics and Biopharmaceutics 67 (2007), pp 387-397, discloses the addition of vitamin A acid and vitamin E to a cellulose acetate solution, and the formation of a nanofiber film by electrospinning, which is useful for drug release applications. Basically, the addition of 5% by weight of retinoic acid/vitamin E to the polymer solution did not help to control the fineness of cellulose acetate 5. In order to improve the prior art problem of agglomeration due to the addition of additives such as nano silver or the like and to affect the spinnability of the fiber, the present invention provides an electrospinning composition containing a tetralin ginseng compound for use in Improve the conductivity of the cellulose acetate polymer solution 'and control the fiber diameter at the same time to obtain a more uniform diameter than the fine money. Rice fiber membrane. The invention further provides a method for reducing the particle size of nanofibers, which is an electrospinning effect of cellulose acetate. SUMMARY OF THE INVENTION In view of the present invention, it is an object of the present invention to provide a conductive silk composition which is characterized in that the conductivity of a solution of a four-Wee-Vitamin-Vitamin solution is used, wherein the composition comprises: "A a homogenous solution containing cellulose acetate and a solvent, wherein, in order to dissolve, the content of the cellulose acetate is 〇〇1, and the horse storm comprises trigaster r1 (four) and the solvent is selected from the group consisting of group one, one, one, Monomethyl hydrazine, dimethylformamide, ethanol, tetrahydrofuran, acetic acid and acetone or a combination of at least two of the above, B) 〇〇1 to 1 compound based on the weight of the above homogeneous solution Derivatives, 20 201016921

ίο 參Οο

Ri為Η或Ck烷基,較佳η, R2及R3各自獨立地為η、p a a R ^ 或 Ci-6 烷基,較佳為 H 及 CH3 , 各自獨立地為H或Ci6燒基,較佳為阳。 雜具體例,靜電纺絲組成物中的醋酸纖維素選自 群組包括早醋酸纖維素、二错酸纖維素及三醋酸纖維素, 三醋酸纖維素為較佳,又以三醋酸纖維素為最佳。早 姆分情_ 2_至 35,000克/莫耳,較佳為25,_至3〇,_克/莫耳。 使用的醋酸纖維素中的乙醯基含量範圍,以醋酸纖維 素篁為基準,為20至80重量%,較佳為3〇至7〇重量。 佳為40至55重量%。 及最 本發明中’以㈣溶液的重量為基準,該醋酸纖維素的含量為 0·01至20重量% ’較佳為0.01至15重量%,及更佳為0.01至8重 量%。 里 —根據本發明,醋酸纖維素係溶於溶劑中以形成均勻溶液,其中 溶劑可為單一溶劑或二種以上溶劑組合的共溶劑混合物,該溶劑可 選自群組包含三氯曱烷、二氯甲烷、二甲基亞砜、二甲基甲醯胺、 15 201016921Ri is hydrazine or Ck alkyl, preferably η, R2 and R3 are each independently η, paa R ^ or Ci-6 alkyl, preferably H and CH3, each independently H or Ci6, preferably It is yang. In a specific example, the cellulose acetate in the electrospinning composition is selected from the group consisting of cellulose acetate, cellulose diacetate and cellulose triacetate, cellulose triacetate is preferred, and cellulose triacetate is used. optimal. Early DM _ 2_ to 35,000 g / Moule, preferably 25, _ to 3 〇, _ g / Mo Er. The ethyl acetate content of the cellulose acetate used is from 20 to 80% by weight, preferably from 3 to 7 % by weight based on the cellulose acetate. Preferably 40 to 55% by weight. And in the present invention, the content of the cellulose acetate is from 0.01 to 20% by weight based on the weight of the (iv) solution, preferably from 0.01 to 15% by weight, and more preferably from 0.01 to 8% by weight. According to the present invention, cellulose acetate is dissolved in a solvent to form a homogeneous solution, wherein the solvent may be a single solvent or a cosolvent mixture of two or more solvent combinations, and the solvent may be selected from the group consisting of trichloromethane, two Methyl chloride, dimethyl sulfoxide, dimethylformamide, 15 201016921

乙醇、四氫呋喃、醋酸及丙酮’較佳A 沾#、、々念,』、 平又住馬此合一氧甲烷與二甲基亞颯 的谷劑或混合醋酸與丙酮的共溶劑。 根據本發明之—具_ ’溶麵佳為包含二㈣餘 砜的共溶劑或包含醋酸與丙酮的共溶劑,其重量比例為、i: 29土至 29 . 1 ’較佳為1 . 至2〇 :丨,及最佳丨:i至n 1。 根據本發明之較佳具體例,使用的溶劑為包含二氯甲燒與 基亞颯之重量_為i :丨的聽劑。又,根據本發明之另二較佳 ❿具體例,使用的溶劑為包含醋酸與丙酮之重量比例為8:2的共^ ',〇 本發明中,所述,’四環素化合物,’及,,其衍生物,,進—步包括四環 . 素化合物及其衍生物之無機鹽類,例如鹽酸鹽等。根據本發明之: f體例,靜電紡絲組成物中的式(1)四環素化合物及其衍生物具有提 咼醋酸纖維素均勻溶液的導電度之功能,除此之外,四環素化合物 亦可進一步作為抗菌劑之用。根據本發明之一較佳具體例,式&所 15 示的環素化合物及其衍生物可選自下列式(II)至(VIII)所示的四環素 0 化合物及其衍生物, ' 多西環素(Doxycycline)Ethanol, tetrahydrofuran, acetic acid and acetone 'preferably A dip #, 々 ,, 』, and live with this oxymethane and dimethyl hydrazine gluten or a mixed solvent of acetic acid and acetone. According to the present invention, the solvent is preferably a cosolvent comprising a di(iv) sulfone or a cosolvent comprising acetic acid and acetone, and the weight ratio thereof is i: 29 soil to 29.1' is preferably 1. to 2 〇: 丨, and best 丨: i to n 1. According to a preferred embodiment of the present invention, the solvent used is a listener comprising dichloromethane and hydrazide having a weight of i: 丨. Further, according to another preferred embodiment of the present invention, the solvent used is a total of 8:2 by weight of acetic acid and acetone, and in the present invention, the 'tetracycline compound, 'and, The derivative thereof includes an inorganic salt of a tetracyclic compound and a derivative thereof, such as a hydrochloride. According to the present invention, the tetracycline compound of the formula (1) and the derivative thereof in the electrospinning composition have the function of improving the conductivity of the cellulose acetate homogeneous solution, and in addition, the tetracycline compound can be further used as For antibacterial agents. According to a preferred embodiment of the present invention, the cyclin compound represented by the formula & 15 and derivatives thereof may be selected from the tetracycline 0 compounds and derivatives thereof represented by the following formulas (II) to (VIII), 'Dorsey Doxycycline

四環黴素(Tetracycline) (II), 201016921Tetracycline (II), 201016921

h3C\ ch3 Hq_CH3 、r '.OHh3C\ ch3 Hq_CH3 , r '.OH

OH O OH Ο O 土黴素(Oxytetracy cline) (III),OH O OH Ο O Oxytetracy cline (III),

HO 0hh -:oh 美諾環素(Minocycline)HO 0hh -:oh Minocycline

氣四環素(Chlortetracy cline)Chlortetracycline (Chlortetracy cline)

n2 HN2 H

(IV), (V), 地美環素(pemeclocycline) (VI), 201016921(IV), (V), pemeclocycline (VI), 201016921

較佳為多西環素(Doxycycline)與四環黴素(Tetracycline),又以多西環 素為最佳。 (VIII), 根據本發明,以醋酸纖維素均勻溶液的重量為基準,式①四環 素化合物及其衍生物的含量為議至丨.⑻重量%,紐為〇 〇1至 〇.20重量0/〇 ’更佳為0.02至〇.12重量%,及最佳為0.02至〇·ι〇重 ίο 在進行纖維靜電紡絲程序期間並可直接 細且分佈均勻。除此之外,===,織 ^只纖維之良好抗_效果。根據本發明 :二、’、、准素 10 15 201016921 小於500奈米的抗菌性醋酸纖維素奈米纖維,以纖維細度為5〇至 500奈米為較佳’及以80至350奈米為最佳。 本發明中’静電紡絲組成物中的醋酸纖維素之均勻溶液主要成 分選擇地可為醋酸纖維與另一種高分子所形成的複合材料,適合的 5 高分子實施例選自群組包含:聚己内酯(poly(s-caprolactone)、聚環 乳乙烯(poly(ethylene oxide)、聚乙烯醇(P〇ly(vinyl alcohol)、聚乳酸 (polylactic acid)、聚氨酯(polyurethane)、聚羥基乙酸(p〇lyglyc〇lic φ acid)、聚屮羥基丁酸酯(P〇ly (β-hydroxybutyrate)、纖維素(ceiiui〇se)、 幾·曱基纖維素(Carboxymethyl Cellulose)、幾丁質(chitin)/幾 丁聚醣 10 (chitosan)、膠原蛋白(c〇Uagen)、明膠(gelatin)、玻尿酸(Hyaluronic acid 或 Hyaluronan)、褐藻酸(aiginate)、聚鏠氨酸(y_p〇ly(glutamic add)。 本發明之靜電紡絲組成物可選擇性地添加表面接枝/固定化物 質或纖維添加物等類添加劑,諸如抗體、酵素、蛋白質、含 官能基之高分子、細菌、細胞、界面活性劑、奈米金屬粒子、微膠 15囊/奈米膠®、藥物、活性碳、奈米碳管、鹽類、聚電解質、觸媒等 _ 物質。 本發明之另一目的在於提供一種改善醋酸纖維素奈米纖維之導 電度及細度之方法,其步驟包含: A) 將〇.〇1至20重量。/。,較佳為〇 〇1至15重量%及更佳為〇 〇ι 2。至8重量%之醋酸纖維素高分子加人—共麵巾,·製一含有醋 酸纖維素高分子溶液,其中共溶劑由選自包含二氯曱烧、二甲基亞 礙、醋酸及丙酮之群組中的二種溶劑所構成,其重量比例為】:29 至 29 : 1 ; B) 將0.01至1.00重量%,較佳為〇 〇1至〇 2〇重量%,更佳為〇 〇2 201016921 至0.12重量从最佳為〇.〇2至請重量%之四環素化合物添 步驟Α)配製的高分子溶液中,以製得具有導電度介於…幻〇 之間的醋酸_素高分子溶液,其巾四環素化合 及其衍生物: ;Preferred are Doxycycline and Tetracycline, and doxycycline is preferred. (VIII) According to the present invention, the content of the tetracycline compound and its derivative of the formula 1 is from 8% to (8)% by weight based on the weight of the cellulose acetate homogeneous solution, and the weight is from 〇〇1 to 〇.20 by weight/ 〇' more preferably from 0.02 to 〇.12% by weight, and most preferably from 0.02 to 〇·ι〇 ίο during the fiber electrospinning process and can be directly fine and evenly distributed. In addition, ===, weaving only a good anti-effect of the fiber. According to the present invention: II. ', and prime 10 15 201016921 Antibacterial cellulose acetate nanofibers of less than 500 nm, preferably having a fiber fineness of 5 to 500 nm and 80 to 350 nm. For the best. In the present invention, the main component of the uniform solution of cellulose acetate in the electrospinning composition may alternatively be a composite material composed of cellulose acetate and another polymer, and a suitable 5 polymer embodiment is selected from the group consisting of: Polycaprolactone (poly(s-caprolactone), poly(ethylene oxide), polyvinyl alcohol (polyvinyl alcohol), polylactic acid (polylactic acid), polyurethane (polyurethane), polyglycolic acid (p〇lyglyc〇lic φ acid), P〇ly (β-hydroxybutyrate), cellulose (ceiiui〇se), Carboxymethyl Cellulose, chitin )/chitosan 10, collagen (c〇Uagen), gelatin, hyaluronic acid or Hyaluronan, aiginate, polyglutamic acid (y_p〇ly (glutamic add) The electrospinning composition of the present invention can selectively add additives such as surface graft/immobilized substances or fiber additives, such as antibodies, enzymes, proteins, functional group-containing polymers, bacteria, cells, surfactants. , nano metal particles, micro-glue 15 /Nano rubber®, drugs, activated carbon, carbon nanotubes, salts, polyelectrolytes, catalysts, etc. _ Substance. Another object of the present invention is to provide an improvement in the conductivity and fineness of cellulose acetate nanofibers. The method comprises the steps of: A) adding 1 to 20% by weight of 〇., preferably 〇〇1 to 15% by weight and more preferably 〇〇ι 2 to 8% by weight of cellulose acetate polymer Adding a human-to-face towel, a solution containing a cellulose acetate polymer, wherein the co-solvent is composed of two solvents selected from the group consisting of dichlorohydrazine, dimethyl sulfoxide, acetic acid and acetone. The weight ratio is: 29 to 29: 1; B) 0.01 to 1.00% by weight, preferably 〇〇1 to 〇2〇% by weight, more preferably 〇〇2 201016921 to 0.12 by weight from the best. 〇2 to the weight% of the tetracycline compound is added to the prepared polymer solution to obtain an acetic acid-based polymer solution having a conductivity between the illusions, the tetracycline compound and its derivatives: ;

ΟΟ

Ri為Η或(:μ6烧基, R2及R3各自獨立地為H、〇H或C〗_6烷基, R4及&各自獨立地為η或Cm烷基, Q將步驟B)製得的高分子溶液通過包含紡嘴與電極 裝置’其操作電壓細介於鮮至8齡之間, ^ 於50奈米至500奈米之間的奈米纖維。 、、出一有直徑;丨 15 根據本發明方法之一具體例,醋酸纖維素 纖維素、二醋酸纖維素及三醋酸纖維素,其酸 醋酸纖維素為較佳,又以三醋酸纖維素為最佳。▲纖維素及三Ri is Η or (: μ6 alkyl, R2 and R3 are each independently H, 〇H or C _6 alkyl, R4 and & are each independently η or Cm alkyl, Q will be prepared in step B) The polymer solution passes through a nanofiber comprising a spinning nozzle and an electrode device whose operating voltage is between about 8 and 35 nm, and between 50 nm and 500 nm. According to one embodiment of the method of the present invention, cellulose acetate cellulose, cellulose diacetate and cellulose triacetate, cellulose acetate acetate is preferred, and cellulose triacetate is used. optimal. ▲Cellulose and three

本發明方法中使用的醋酸纖維素具有相對分子旦 至35,000克/莫耳,較佳為25,〇〇〇至3〇,〇〇〇克/莫乾圍為20,00C 本發明方法中使用酸纖維素中的乙轉含 80重量°/0,較佳為3〇至7〇重量%,最 &圍為2〇至 取佳為40至55重量%,以 12 201016921 醋酸纖維素重量為基準。 根據本發明之方法,輔可為二種溶敝合的共溶劑混合物, 5The cellulose acetate used in the process of the invention has a relative molecular weight of 35,000 g/mole, preferably 25, 〇〇〇 to 3 〇, and 〇〇〇克/莫干围为20,00C. The acid used in the process of the invention The B-transfer in the cellulose contains 80% by weight/0, preferably 3% to 7% by weight, most preferably 2% to preferably 40% to 55% by weight, based on the weight of 12 201016921 cellulose acetate. . According to the method of the present invention, the co-solvent mixture of the two kinds of dissolved complexes may be used, 5

2020

較佳為混合二氯甲紗二甲基亞_共賴或混合醋酸與丙嗣的 共溶劑。本發明方法巾使_賴為二氣伙與 劑,其重量比例較佳為1:10至20:1,更佳1:1至18:^= 為1 . 1。又’本發明方法中使用的溶劑為醋酸與_的共溶劑,並 重量比例較佳為1 : 1()至2():卜更佳為〗:i至18 :卜及最佳^ 8=2〇 本發明中,利用靜電紡絲(electrospinning)方式,藉高電壓(例如 5至8〇kV)使醋酸纖維素高分子均勻溶液帶有電荷,並將 米纖維乾燥與固化。根據本發明之—具體例,方法中,在提供高= 壓的情況下,_裝配有計量幫浦的注射器將高分子溶液喷出,每 逐漸增加1場強度後’纽卿的毛崎尖喊生半_流體表: 延伸形成圓錐狀(如所謂的泰勒圓錐形(Tayl〇r c〇ne));繼續增加電場 強度’-旦翻某臨界值,其靜賴斥力超過赫表面張力值琢 圓錐形头端之帶電荷流體產生儒現象,在此過程巾溶劑蒸發固 形成奈米纖維於收集ϋ上。於靜電紡絲裝置中,—電極 紡絲〉谷液或縣體,另—電酬連接轉躺或靜止的收集器。、 、根據本發明之方法’醋g_維素為選自單醋酸纖維素、二 纖維素或三醋酸纖維素’以料織纖維素及三_纖維素為:, 2三醋酸_麵錄。«本發明,可細纽薄卿式的萨 酸纖維素材料。 曰 根據本發财法之_具酬,方法巾的四環素化合物及 物係選自如上所述多西環素、四環黴素、土黴素、美諾環素、、氯四 20 201016921 ❹ ίο 15 ❿ 20 玉衣素、地美環素或替加環辛 又以多西環素為最佳。*中以夕西哀素及四環黴素為較佳, 外’除了_提高及控制奈米纖賴_導 外’同時可降低奈米纖維的細度且使粒徑分佈更均,^ 有均㈣馳餘崎料製得具 又,根據本發明之方法可製得具有改善的導雜 。根據本發明,獲得的奈^維 米為ir以G至奈米為較佳,及⑽至现奈 太虫U面’本㈣_靜電紡絲技術將醋酸纖維素纖維製備成 ϊ等於其中添加了四環素化合物(諸如多轉素、四環黴 素專)’因而賦予醋酸纖維素奈米纖維之抗菌功能。 . 米纖:本發明之再又—目的在於製造-種具有抗菌性功能的奈 根據本發明獲得的醋酸纖維素奈米纖維膜材可進—步加工 成戶:需的產品形式’使用的加工方式例如包含:界面聚合、塗佈^ 摺璺、加熱、電漿改質、接枝、固定化、交聯、親水化/疏水化、貼 合或在其絲材(何織布、金屬㈣等)上纺絲等。 本發明獲得的醋酸纖維素奈米纖維膜材可進-步加卫而形 需纖維型態,例如實㈣、多錄型、純型及巾㈣纖維等。 本發明獲得的奈米纖_材可單獨錢或與其絲f(如不織 布、聚合反應、貼合細等)—起組合,其可再進—步經加工,例如 14 201016921 201016921 5Preferably, a mixed solvent of dichloromethyl dimethyl ketone or a mixed solvent of acetic acid and propylene is used. The method of the present invention has a weight ratio of preferably from 1:10 to 20:1, more preferably from 1:1 to 18:^= of 1.1. Further, the solvent used in the method of the present invention is a co-solvent of acetic acid and _, and the weight ratio is preferably 1:1 () to 2 (): more preferably: i to 18: and the best ^ 8 = 2. In the present invention, a cellulose acetate polymer homogeneous solution is charged by a high voltage (for example, 5 to 8 〇 kV) by an electrospinning method, and the rice fiber is dried and solidified. According to the specific example of the present invention, in the method of providing high=pressure, the syringe equipped with the metering pump sprays the polymer solution, and each time the field strength is gradually increased, Raw half _ fluid table: extended to form a conical shape (such as the so-called Taylor conical (Tayl〇rc〇ne)); continue to increase the electric field strength '- once turned a certain threshold, its static repulsion exceeds the Herhe surface tension value 琢 conical The charged fluid at the head end produces a Confucian phenomenon, in which the solvent evaporates to form nanofibers on the collection crucible. In the electrospinning device, the electrode is spun, the valley liquid or the county body, and the electric collector is connected to the reclining or stationary collector. According to the method of the present invention, the vinegar g-vitamin is selected from the group consisting of cellulose monoacetate, dicellulose or cellulose triacetate, and the cellulose acylate and tri-cellulose are: «The present invention is a fine succinyl cellulose material.四 According to the present financing method, the tetracycline compound and the system of the method towel are selected from the group consisting of doxycycline, tetracycline, oxytetracycline, minocycline, and chlorotetracycline 20 201016921 ❹ ίο. 15 ❿ 20 Yuxisu, dimecycline or tigecycline is best with doxycycline. * It is better to use oxime and tetracycline, and the external 'except _ improve and control the nanofiber _ outside the outer diameter' can reduce the fineness of the nanofiber and make the particle size distribution more uniform. The (four) Chi Yuqi material is produced, and the improved impurity is obtained according to the method of the present invention. According to the present invention, it is preferred that the obtained weiweiwei is ir with G to nano, and (10) to the present Naito worm U-face 'this (four)_electrospinning technique, the cellulose acetate fiber is prepared to be equal to the addition thereof. Tetracycline compounds (such as multiplexin, tetracycline) provide the antibacterial function of cellulose acetate nanofibers. Rice fiber: a further object of the present invention - the purpose of producing a kind of antibacterial function, the cellulose acetate nanofiber membrane obtained according to the invention can be further processed into a household: the desired product form 'used processing The method includes, for example, interfacial polymerization, coating, entanglement, heating, plasma modification, grafting, immobilization, crosslinking, hydrophilization/hydrophobization, lamination, or in its wire (when weaving, metal (four), etc. ) Spinning and the like. The cellulose acetate nanofiber membrane obtained by the present invention can be further modified to form a fiber type, such as a solid (four), a multi-recorded type, a pure type, and a towel (four) fiber. The nanofiber material obtained by the present invention can be combined with or with its wire f (e.g., non-woven, polymerization, fine bonding, etc.), which can be further processed, for example, 14 201016921 201016921 5

1515

20 、酵素固定化、樹脂塗佈、熱壓等爾 療^=奈__㈣麟各糊途,特別是醫 明丄T淨化(Η_Ρ6池―)/血液透_em〇dia㈣:使财 明靜電紡絲奈米纖維膜材應用於血液淨化。 析膜作為半透析膜來=:==米纖維膜材可用於血液透 Γίϊί 或抗體等㈣,藉由酵素或抗體結合與_ 質產生結合或反應之特性來達到生物感測之效果。 舰3f/轉 =(DrugDelivery):本發明靜電紡絲組成物製成的奈米 纖、准中加入樂劑(例如藥物微囊,藥物顆粒等形式),可選用直接釋 2或控制釋放(利用溫度、酸驗值、親水親油特性等)等方式釋放藥 《創傷敷材(wound dressing) ··以本發明靜電纺絲組成物製成的 =米纖維膜適合供作為紐之覆蓋物,除以單成份纖維直接應 用外,也可以複合纖維形式應用。 5.組織工程支架(Tissue engineering scaff〇ld):以本發明靜電紡絲 組成物製成的m轉為組織球支架之應n譯成份纖維 直接應用外,也可以複合纖維形式應用。 【實施方式】 15 201016921 本發明將藉由下着關更詳魏_,該實施例不意欲以任 何方式限制本發明範圍,雖然設於大範圍的數字範圍及參數範圍是 近似值,但儘可能精確地紀錄在特定的實施例中的數值。 5 實施例 本發明之實施例及比較例中使用的靜電纺絲裝置及操作條件如 下說明: Ο L靜電紡絲裝置(型號ESL-004,梭環公司製造”包含一個使 高分子溶崎出金料頭_進裝置,—織置高分子溶液的針 10筒’-支金屬針’-個電源供應器與—個收集纖維的基板。 2.操作條件:靜電紡絲操作的電壓為2〇 kv,推進壓力為αι 贿,金屬針規格25 gage,金屬針尖端至基板之距離為1〇公分。 15 根據本發明之實施例及比較例獲得的醋酸纖維素奈米纖維靜電 馨 纺、'糸組成物及其臈材之特性依據下述方法進行評估及測定: h奈米纖維結構/奈米纖維粒徑分佈 利用掃描式電子顯微鏡(SEM)裝置(型號J0EL JSM_67〇〇F, J〇EL公司製造)’ 5,〇〇〇倍率,觀察奈米纖維結構及細 20 佈情形。 16 1 .高分子溶液導電度 利用電阻計(型號SC-SRT Surface Resistant,宏星電機股份有限 A司製造)檢測高分子溶液的導電度(1/Ω)。 201016921 3.抗_效果 A) 定性抑菌性測試:使用標準AATCC (American Association of Textile Chemists and Colorists) Test Method 147 定性測試奈米纖維膜 5 材的抑菌性,其操作流程如下所述: -準備細卤培養基:均勻混合23.5克洋菜膠(Nutrient Agar)/1升 祭顧水與8克營養培養基(Nutrient Broth)/l升蒸顧水,之後將形成 ❿ 的培養基在高溫高壓滅菌釜中殺菌,以製得細菌培養基; -菌液培養.將金黃色葡萄球菌(staphylococcus aureus)(格蘭氏陽 10 性菌)加入該經滅菌的培養基中培養18至24小時; -測試樣品:準備尺寸2公分X 2公分之經過滅菌的靜電紡絲 醋酸纖維素奈米纖維膜樣品; -試驗步驟:將經滅菌的培養基置於無菌操作台中,於未凝固前 倒入培養皿’以製成平板培養基;在平板培養基中接種菌株並以L 15 型玻璃棒均勻塗佈,及將奈米纖維膜與以塗佈方式製成的薄膜利用 φ 無菌鉗子小心地放置於洋菜膠表面及與平板培養基貼合,在3Tc溫 度培養箱中下培養24小時; -效果坪估:以膜材抑菌圈之大小進行評估奈米纖維的抗菌效 果’抑菌圈越大表示抑菌效果越佳。 20 B) 疋里抗卤性測试.使用jjs indust]:iai l 1902 標準方法進行測試,其操作流程如下所述: 七、式驗的生物·金黃色葡萄球菌(staphylococcus aureus) 準備細菌培養基.將5克牛肉汁(beef extract)、10克蛋白腺 201016921 (peptone)、5克氯化鈉、15克洋菜膠與1000毫升的純水置入燒瓶中 中均勻混合;在沸水浴中加熱以充份溶解混合液的成分,隨後將混 合液的PH值調控至pH 7.0 ±0.2 ;接著,以高溫高壓滅菌釜殺菌, 以形成細菌培養基; -測試樣品:準備尺寸4〇毫米X4〇毫米之經過滅菌的靜電紡絲 醋酸纖維素奈米纖維膜樣品; -試驗步驟:20, enzyme immobilization, resin coating, hot pressing and other treatments ^= Nai __ (four) Lin each paste way, especially the medical 丄T purification (Η _ Ρ 6 pool ―) / blood through _em〇dia (four): make Cai Ming electrospinning Silk nanofiber membranes are used for blood purification. The membrane is used as a semi-dialysis membrane =:== The rice fiber membrane can be used for blood permeation or antibodies (4), and the effect of biosensing can be achieved by the combination of enzyme or antibody binding and _ quality. Ship 3f / turn = (DrugDelivery): the nanofiber made of the electrospinning composition of the present invention, the quasi-medium agent (such as drug microcapsules, drug particles, etc.), can be directly released 2 or controlled release (utilization) "Wound dressing" by means of temperature, acid value, hydrophilic and lipophilic properties, etc. · The fiber membrane made of the electrospinning composition of the present invention is suitable for covering as a covering, except It can be applied directly to single-component fibers or in the form of composite fibers. 5. Tissue engineering scaff〇ld: The m-turned into the tissue ball holder made of the electrospinning composition of the present invention can be applied directly or in the form of a composite fiber. [Embodiment] 15 201016921 The present invention will be more detailed by the following description, and the embodiment is not intended to limit the scope of the invention in any way, although the numerical range and parameter range set in a wide range are approximate, but are recorded as accurately as possible. The values in a particular embodiment. 5 EXAMPLES The electrospinning apparatus and operating conditions used in the examples and comparative examples of the present invention are as follows: Ο L electrospinning apparatus (model ESL-004, manufactured by Shuttle Ring Co., Ltd.) contains a polymer for melting gold Feed head_input device, needle 10 tube '-metal needle' for weaving polymer solution--a power supply and a substrate for collecting fibers. 2. Operating conditions: The voltage of electrospinning operation is 2〇kv The propulsion pressure is αι bribe, the metal needle size is 25 gage, and the distance between the tip of the metal needle and the substrate is 1 〇 cm. 15 The cellulose acetate nanofiber obtained by the examples and the comparative examples of the present invention is electrostatically spun, '糸 composition The properties of the material and its coffin were evaluated and determined according to the following methods: h Nanofiber structure/nano fiber particle size distribution using a scanning electron microscope (SEM) device (Model J0EL JSM_67〇〇F, manufactured by J〇EL) ) 5, 〇〇〇 magnification, observe the structure of nanofibers and fine 20 cloth. 16 1. The conductivity of polymer solution is measured by electric resistance meter (model SC-SRT Surface Resistant, manufactured by Hongxing Electric Co., Ltd.) molecule Conductivity of liquid (1/Ω) 201016921 3. Anti-effect A) Qualitative bacteriostatic test: Qualitative test of antibacterial properties of nanofiber membrane 5 using standard AATCC (American Association of Textile Chemists and Colorists) Test Method 147 Sex, the operation process is as follows: - Prepare the fine halogen medium: uniformly mix 23.5 grams of agar extract (Nutrient Agar) / 1 liter of water and 8 grams of nutrient medium (Nutrient Broth) / l liter of steam, then form The medium of cockroach is sterilized in a high temperature autoclave to prepare a bacterial culture medium; - broth culture. Staphylococcus aureus (Glendido 10) is added to the sterilized medium to culture 18 24 hours; - Test sample: Prepare a sample of sterilized electrospun cellulose acetate nanofiber membrane with a size of 2 cm x 2 cm; - Test procedure: Place the sterilized medium in an aseptic table and pour before coagulation Into the culture dish 'to make a plate medium; inoculate the strain in the plate medium and uniformly coat with a L 15 type glass rod, and use the nanofiber film and the film formed by coating to utilize φ Sterile pliers were carefully placed on the surface of the vegetable gum and adhered to the plate medium, and cultured in a 3Tc temperature incubator for 24 hours. -Effect of the evaluation: The antibacterial effect of the nanofibers was evaluated by the size of the membrane inhibition zone. The larger the inhibition zone, the better the bacteriostatic effect. 20 B) The anti-halogen test of 疋. Use jjs indust]: iai l 1902 standard method to test, the operation process is as follows: VII, test organisms Staphylococcus aureus Prepare the bacterial culture medium. Put 5 grams of beef extract, 10 grams of protein gland 201016921 (peptone), 5 grams of sodium chloride, 15 grams of acacia and 1000 ml of pure water into the flask. Medium and medium homogeneous mixing; heating in a boiling water bath to fully dissolve the components of the mixture, and then adjusting the pH of the mixture to pH 7.0 ± 0.2; then, sterilizing in a high temperature autoclave to form a bacterial culture medium; - test sample : Preparing a sample of sterilized electrospun cellulose acetate nanofiber membrane having a size of 4 mm × 4 mm; - Test procedure:

1515

Day 1 :菌活化,將菌株接入培養液中在3Tc的培養箱中培 養18至24小時;Day 1 : bacterial activation, the strain was introduced into the culture solution and cultured in a 3Tc incubator for 18 to 24 hours;

Day 2 :計算初始菌數,稀釋為每毫升1χ1〇5的菌液濃度, 再將此液體均勻滴在膜上直到膜材吸滿菌液即可; 然後再將吸滿菌液的膜材置於^它的培養箱中培養 18至24小時; 口Day 2: Calculate the initial bacterial count, dilute to a concentration of 1χ1〇5 per ml, and then evenly drip the liquid onto the membrane until the membrane is filled with the bacterial solution; then place the membrane filled with the bacterial solution Incubate in its incubator for 18 to 24 hours;

Day 3 :將Day 2的膜置於2〇毫升的舰中震盡i分鐘以 上,之後,將獲得的液體稀釋至原有濃度的1〇_5, 取此稀釋液體在洋菜平板上作塗佈,在抓的轉 箱中培養18至24小時; °Day 3: The Day 2 film is placed in a 2 〇 ml ship for more than i minutes. After that, the obtained liquid is diluted to the original concentration of 1〇_5, and the diluted liquid is applied to the acacia plate. Cloth, cultivated in a trough for 18 to 24 hours; °

Day4:計算Day3的結果; f果雜:分鱗算得般_奈米齡之 大於0時’蚊樣品具有殺菌作用 抑 2時,評定樣品具有抑g作用。 有田抑菌值大於 導電度測試 ::r素靜電纺絲组成物配製及 20 201016921 配衣* 3有叫魏合物之靜電騎、單醋酸_素溶液作為對 知組。 秤取15克單醋酸纖維素原料(相對分子 脇公顿人玻魏中,於射添加含有⑽克醋酸與&= 之醋酸/_(8.2)聽劑,以震盪方式使 參 10 15 20 :=素均勻溶液。進行上述獲得的溶液之導電度二 實施例1 秤取I5克單魏_素顧(相對分子量29,_ 驗公司)置入玻璃瓶中,於其中添加 == 之醋酸/_(8 : 2)絲劑ϋ與17克丙酮 醋酸纖維素均勻溶液。 Λ使均勻’以獲得單 秤取2克的多西環素加人上述獲得的單醋酸 、 中,混合均勻後,獲得含有_%多西環素之單醋酸纖維夸=液 絲均勻溶液,測試該溶液的導電度,結果如表工所示。、’、素靜电纺 實施例2 如同貝施例1之方式’惟於單醋酸纖維素靜 的多西環素含量為4克,以獲得含有_%多西環溶液中 素靜電紡絲均勻溶液。接著測試該均勻声之早醋酸纖維 所示。 电度,結果如表1Day4: Calculate the result of Day3; f. Miscellaneous: the scale is calculated as the case. When the nanometer age is greater than 0, the mosquito sample has a bactericidal effect. When the temperature is 2, the sample is evaluated to have a g-suppressing effect. A field antibacterial value is greater than the conductivity test ::r electrospinning composition preparation and 20 201016921 dressing * 3 there is called Wei compound static riding, monoacetic acid _ solution as a pair of knowledge. Weigh 15 grams of monoacetate raw material (relative to the molecular flavonoids in the glass, add the (10) grams of acetic acid and &= acetic acid / _ (8.2) listener, in a shock to make the reference 10 15 20: = homogeneous solution. Conductivity of the solution obtained above was carried out. Example 1 I5 g of monofilament _ _ Gu Gu (relative molecular weight 29, _ inspection company) was placed in a glass bottle, and == acetic acid / _ was added thereto (8: 2) a uniform solution of silk mash and 17 g of acetone cellulose acetate. 均匀 Make uniform 'to obtain 2 gram of doxycycline plus a single acetic acid obtained above, and mix well to obtain _% doxycycline monoacetate fiber = liquid filament uniform solution, test the conductivity of the solution, the results are shown in the table. ', the electrospinning example 2 as in the case of Bay example 1 The cellulose monoacetate had a stable doxycycline content of 4 g to obtain a uniform solution of electrospinning containing _% of the doxycycline solution. The uniform sound of the early acetate fiber was then tested. 1

比較例B 19 201016921 配製不含有四環素化合物之三醋酸纖維素靜電紡絲溶液作為對 照組。 …、 秤取8克三贈酸纖維素原料(乙醯基含量43至49重量%,商品 AL-181005 ’購自Sigma_Aldrich)置入玻璃瓶中,於其中添加幻克 5 二氯曱烷,讓溶液保持在40°C溫度下靜置一天後,再加入42克二 甲基亞礙’以震盤方式使溶液混合均勻,以獲得於二氯曱烧/二曱基 亞砜(1 : 1)共溶劑中之三醋酸纖維素均勻溶液。進行上述獲得的二 0 液之導電度檢測,結果如表1所示。 ίο 實施例3 秤取8克三醋酸纖,素原料(乙醯基含量43至49重量%,商品 1181005 ’購自Sigma-Aldrich)置入玻璃瓶中,於其中添加42克 一氯曱烷,讓溶液保持在40¾溫度下靜置一天後,再加入42克二 甲基亞碾’以震盪方式使溶液均勻混合,以獲得三醋酸纖維素均句 15 溶液。 ❹ 秤取h84克的多西環素加入上述獲得的三醋酸纖維素均勻溶液 中,混合均勻後,獲得含有〇〇2%多西環素之三醋酸纖維素靜電紡 絲均勻溶液,測試該溶液的導電度,結果如表丨所示。 2〇 實施例4 如同貫施例3之方式’惟於三醋酸纖維素靜電紡絲均勻溶液中 的多西環素含量為3.68克’以獲得含有〇.〇4〇/0多西環素之三醋酸纖 維素靜電紡絲均勻溶液。接著测試各溶液的導電度,結果如表i所 示0 20 201016921 實施例5 如同實施例3之方式’惟於三醋酸纖維素靜電纺絲均勻溶液中 素含量為736克’轉得含有_%多西環素之三醋酸纖 ^素靜電_物錄。㈣戦各溶㈣魏度,躲如表i所 〇 貫施例6 丨。的夕如同m實施例3之方式,惟於三醋酸纖維素靜電纺絲均勻溶液中 雄二,素含量為9.2克’以獲得含有G1G%多西環素之三醋酸纖 二。靜電紡絲均句溶液。接著測試各溶液的導電度,結果如表i所Comparative Example B 19 201016921 A cellulose triacetate electrospinning solution containing no tetracycline compound was prepared as a control group. ..., weighed 8 grams of three free acid cellulose raw materials (ethyl mercapto content of 43 to 49% by weight, the commodity AL-181005 'purchased from Sigma_Aldrich) placed in a glass bottle, in which added magical 5 dichlorodecane, let After the solution was kept at 40 ° C for one day, add 42 g of dimethyl sulfoxide to mix the solution evenly in a shock disk to obtain dichlorohydrazine/dimercapto sulfoxide (1:1). A homogeneous solution of cellulose triacetate in a cosolvent. The conductivity measurement of the above obtained liquid was carried out, and the results are shown in Table 1. Ίο Example 3 8 g of triacetate fiber was weighed, and the raw material (ethylene bromide content 43 to 49 wt%, commercial 1181005 'purchased from Sigma-Aldrich) was placed in a glass bottle, and 42 g of chlorodecane was added thereto. After allowing the solution to stand at 403⁄4 for one day, add 42 g of dimethyl sub-milling to uniformly mix the solution in an oscillating manner to obtain a solution of cellulose triacetate. h Weighing 84 g of doxycycline into the uniform solution of cellulose triacetate obtained above, and after mixing uniformly, obtain a uniform solution of cellulose triacetate electrospinning containing 2% doxycycline, and test the solution. The conductivity is shown in the table. 2) Example 4 As in the method of Example 3, except that the content of doxycycline in the trimethylcellulose electrospinning homogeneous solution was 3.68 g' to obtain 〇.〇4〇/0 doxycycline A cellulose triacetate electrospinning homogeneous solution. Next, the conductivity of each solution was tested, and the results are shown in Table i. 0 20 201016921 Example 5 As in the case of Example 3, except that the content of the cellulose in the triacetate electrospinning homogeneous solution was 736 g. % doxycycline triacetate fibrin electrostatic _ record. (4) 戦 溶 四 (4) Wei degree, hiding as shown in Table 施 Example 6 丨. The eve was the same as that of Example 3 except that in the cellulose triacetate electrospinning homogeneous solution, the male content was 9.2 g' to obtain the triacetate fiber containing G1G% doxycycline. Electrospinning uniform solution. Next, the conductivity of each solution was tested, and the results are shown in Table i.

如表1所示’與未含有多西環素的組成物(比較例A及比較例 %相較下’實施例1至6所獲得的靜電紡絲組成物的導電度有提高 的傾向。 21 201016921 n.靜電紡絲奈米纖維製傷及纖維 比較例c 將比較例A獲得的未含 行靜電紡絲程序。在静m錄之早醋酸纖維素均勻溶液進 的單醋酸纖維素㈣驗,、:崎㈣裝填由比較例A所獲得 該均勻溶液喷出。在靜電料,裝置將溶液擠㊉金屬針頭,將 固化,於收集器上分使溶液中的溶劑蒸發⑽ e 10 15 ❹ 圖I、上圖m轉行細度及分布的_,結果如表2及 實施例7 η將-^1例1沾之含有〇.〇2%乡西環素的單醋酸纖維素均勻溶 液進灯靜電紡絲程序。在靜電紡絲裝置的針筒魄填 獲得的單_纖維素均勻溶液,_推進裝置將溶液擠出金屬^ 頭’將該均自溶液噴出。在靜電_過程巾,使溶液中的溶劑蒸發 及之後HHb ’於收集H上分別形成奈米纖維。 對上述开>成的奈米纖維進行細度及分布的檢測結果如 圖2a、圖2b所示。 實施例8 如同實施例7之靜電紡絲程序,將實施例2獲得之含有〇 〇4% 多西環素的單醋酸纖維素均勻溶液進行靜電紡絲程序,以形成奈米 纖維。 丁、 對上述形成的奈米纖維進行細度及分布的檢測’結果如表2及 22 201016921 圖3a、圖3b所示。As shown in Table 1, 'the conductivity of the electrospinning composition obtained in Examples 1 to 6 was lower than that of the composition containing no doxycycline (Comparative Example A and Comparative Example %). 21 201016921 n. Electrospun nanofiber injury and fiber comparison example c The electrospinning procedure obtained in Comparative Example A was not included. In the case of monoacetic acid cellulose (4) in which the cellulose acetate was uniformly solutiond, ,: Saki (4) loading The uniform solution obtained by Comparative Example A is sprayed. In the electrostatic material, the device squeezes the solution into a metal needle, solidifies it, and distributes the solvent in the solution on the collector (10) e 10 15 ❹ Figure I The above picture m is transferred to the fineness and distribution of _, the results are as shown in Table 2 and Example 7 η - ^ 1 case 1 containing a uniform solution of monoacetate containing 〇. 〇 2% cycline into the lamp electrospinning Wire program: a single-cellulose uniform solution obtained by filling the syringe of the electrospinning device, and the _ propelling device extrudes the solution into the metal head to eject the solution from the solution. In the static _ process towel, the solution is made The solvent is evaporated and then HHb' is formed on the collected H to form nanofibers respectively. The results of the fineness and distribution of the nanofibers are shown in Fig. 2a and Fig. 2b. Example 8 As in the electrospinning procedure of Example 7, the bismuth 4% doxycycline obtained in Example 2 was obtained. The monoacetate uniform solution was subjected to an electrospinning process to form nanofibers. D. The fineness and distribution of the nanofibers formed were measured. The results are shown in Tables 2 and 22, 201016921, Figs. 3a and 3b.

比較例D 抑如同一比較例C之靜電纺絲程序,將比較例b獲得的未含有多西 5環素之三醋酸纖維素均勻溶液進行靜電紡絲程序,以形成奈米纖 維。 對上述形_奈錢軸行細度及分布的_,絲如表2及 魯 圖4a、圖4b所示。 10 15 ❹ 20 實施例9 夕如同實施例7之靜電纺絲程序,將實施例3獲得之含有讀% 素的三醋酸纖維素均勻溶液進行靜電_轉,⑽成奈米 對上述形㈣m軸行細度及分布的檢測如及 圖5a、圖5b所示。 。 實施例10 如同實施例7之靜電紡絲程序,將實施例4獲得之含有〇〇4% =環素的三献_素均勻溶賴行靜電_轉,⑽成奈米 對上述形成的奈米纖維進行細度及分布的檢測,結果如表2及 圖6a、圖6b所示。 實施例11 23 201016921 如同實施例7之靜電紡絲程序,將實施例$獲得之含有 多西核素的三紐雜料自溶峡行靜電麟程序,以形成奈米 纖維。 對上述形成的奈錢維進行細度及分布雜測,結果如表2及 圖7所示。 實施例12 參 如同實施例7之靜電紡絲程序,將實施例ό獲得之含有〇·1〇〇/0 多西環素的二醋酸纖維素均勻溶液進行靜電紡絲程序,以形成奈米 10 纖維。 對上述形成的奈錢維進行細歧分布雜測,結果如表2及 圖8所示。 表2 tbfe例 C 雜例 7 細列 8 tbfe例 D 9 雜例 10 細到 11 雜例 12 單醋酸纖維 素,% 0 15 15 二赌酸纖維 素,% 0 8 8 8 8 多西支衣素,% 0 0.02 0.04 0 0.02 0.M 0.08 0.10 纖維平均直徑 ㈣ 521.47 ±40138 441*50 珊.58 35936 ±61.84 「1186.03 ±81229 49029 ±123.13 150.92 ±6634 105.48 ±33.73 96.70 i3237 由實施例結果顯示隨著多西環素的含量增加,奈米纖維的粒徑 降低及細度均勻分布的效果更佳。如表2所示,與未含有多西環素 之醋酸纖維素靜電紡絲組成物(比較例C及比較例D)相較下,使用 本發明之醋酸纖維素靜電紡絲組成物(實施例7至12)經過靜電紡絲 24 201016921 ^ 〇 ^ la.2a. ^ = = 6=θ7及8所測得的纖維粒徑分佈顯示,當奈米纖維 ==含1增加時,其粒徑變小且傾向均一。在上述實施例 物开/_^:°2至1()%多崎素的三醋酸纖維素靜電紡絲組成 勿形成的絲_在細纽均恤上具妓崎的 、 6a、7 及 8 所示。 4 ^ ui 籌 10 ❹ 20 III.奈米纖維膜材之抗菌性試驗 A) 定性抑菌試驗 =上述定性抑菌性試驗方法,取由未含有多西環素的三醋酸 彡成的奈概物(比_ d)與含有_多 ί 口哀t 纖維素溶液靜電纺絲形成的奈米纖維膜(實施例9) 捸口口進仃抑菌性能力之比較及評估。 素太平顯7如圖9績不’未添加多西環素的三醋酸纖維 對==膜在培養基上沒有抑_形成,亦即不具有抑菌效果; 有i地釋ίί Γ.°Γ°多西環素的三醋酸纖維素奈米纖維膜由於能 b西喊,在樣品周®會形成抑賴,如圖%所示, 因而找為具有觸能力。 B) 定量抗菌性測試 施上抗菌試驗方法,取樣含有0%(比較例D)、〇.〇2%(實 输她各 實施例1〇)及〇.〇8%(實施例U)之多西環素的三醑酸 以:平ίΐ液靜電紡絲形成的奈米纖維騎行檢麻菌值與抑菌值 〇平估不、米纖維的抗菌能力,如表3所示。 25 201016921Comparative Example D In the electrospinning procedure of Comparative Example C, a uniform solution of cellulose triacetate not containing doxycycline obtained in Comparative Example b was subjected to an electrospinning procedure to form a nanofiber. For the above-mentioned shape, the fineness and distribution of the axis are shown in Table 2 and Lutu 4a and 4b. 10 15 ❹ 20 Example 9 As in the electrospinning procedure of Example 7, the uniform solution of cellulose triacetate containing the read % obtained in Example 3 was subjected to electrostatic_rotation, (10) into nanometers to the above-mentioned shape (four) m-axis row. The detection of fineness and distribution is shown in Figures 5a and 5b. . Example 10 As in the electrospinning procedure of Example 7, the three-concentration containing 〇〇4%=cycline obtained in Example 4 was uniformly dissolved and electrolyzed, (10) into nanometers to form the above-mentioned nanometer. The fibers were examined for fineness and distribution, and the results are shown in Table 2 and Figures 6a and 6b. Example 11 23 201016921 As in the electrospinning procedure of Example 7, the poly-nuclear-containing tri-nuclear material obtained from Example 10 was self-dissolving the electric lining procedure to form nanofibers. The fineness and distribution miscellaneous measurements were carried out on the above formed nevi, and the results are shown in Table 2 and Figure 7. Example 12 Referring to the electrospinning procedure of Example 7, the uniform solution of cellulose diacetate containing 〇·1〇〇/0 doxycycline obtained in Example 进行 was subjected to an electrospinning procedure to form nano 10 fiber. The fine-distribution miscellaneous measurement of the nevavir formed above was carried out, and the results are shown in Table 2 and Figure 8. Table 2 tbfe Example C Hybrid 7 Subtle 8 tbfe Example D 9 Hybrid 10 Fine to 11 Hybrid 12 Monoacetate, % 0 15 15 Two gammonic acid cellulose, % 0 8 8 8 8 Dorsalin ,% 0 0.02 0.04 0 0.02 0.M 0.08 0.10 Average fiber diameter (4) 521.47 ±40138 441*50 珊.58 35936 ±61.84 "1186.03 ±81229 49029 ±123.13 150.92 ±6634 105.48 ±33.73 96.70 i3237 The content of doxycycline is increased, and the effect of reducing the particle size of the nanofibers and uniformly distributing the fineness is better. As shown in Table 2, the cellulose acetate electrospinning composition containing no doxycycline (Comparative Example) C and Comparative Example D) In contrast, the cellulose acetate electrospinning composition of the present invention (Examples 7 to 12) was subjected to electrospinning 24 201016921 ^ 〇 ^ la. 2a. ^ = = 6 = θ7 and 8 The measured fiber particle size distribution shows that when the nanofiber ==1 is increased, the particle size becomes smaller and tends to be uniform. In the above examples, the material is opened / _^: ° 2 to 1 ()% The cellulose triacetate electrospinning consists of a silk that is not formed. It is shown in 6a, 7 and 8 on the thin button. 4 ^ ui 筹 10 ❹ 20 III. Antibacterial test of nanofiber membrane A) Qualitative bacteriostatic test = the above qualitative bacteriostatic test method, taking the ruthenium of triacetate without doxycycline ( Comparison and evaluation of the bacteriostatic ability of the nanofiber membrane formed by electrospinning of the cellulose solution containing _ ί 口 哀 纤维素 纤维素 纤维素 纤维素 实施 。 。 。 。 。 。 。 。 。 。 。 。 。 。 9 9 The performance is not 'the addition of doxycycline triacetate pair == membrane does not inhibit _ formation on the medium, that is, does not have antibacterial effect; there is i to release ίί Γ. ° Γ ° doxycycline triacetate Cellulose nanofiber membranes can be suppressed by the sample week, as shown in Figure 5%, so they are found to have the ability to touch. B) Quantitative antibacterial test is applied to the antibacterial test method, the sample contains 0% (Comparative Example D), 〇.〇2% (actually transferred to each of her Examples 1〇) and 〇.〇8% (Example U) of the doxycycline triterpenic acid was formed by electrospinning of a flat liquid The value of the bacteria and the antibacterial value of the nanofiber riding were not evaluated, and the antibacterial ability of the rice fiber was as shown in Table 3. 25 201016921

❿ 的多顯示,含有嶋至喔 生物的醋酸纖特靜電紡:,知’添加有四環素化合物或其衍 jo 勻。再者,由於加入的四環素化合物或 物本身亦具批相能,上 明形成的奈米纖維膜材同時可具有優異的抗菌=了根據本發 1 上頻實施·__本_之技制敍_,使 n領域之通常知識者能瞭解本案之目岐内容 二,用關限本㈣,故在未絲本發明之⑽及精神所完I 的改良或修_發明,仍應涵蓋在本發明範嗜内。 【圖式簡單說明】 圖la為含有0%多西環素之單醋酸纖維素(CA)奈米纖維膜⑽交 26 15 201016921 例C)之粒徑分佈 圖lb c)之腿ίί有叫西環素之單隨_她_膜喊例 e 10 15 ❹ 例η圖之= 佈有〇.〇2%多西環素之單错酸纖维素奈米纖維罐施 例==瞧乡神細__梅軸(實施 圖3a為含有0.04%多西環素之單醋 例8)之粒齡佈。 付早轉米_膜(實施 圖3b為含有0.04%乡西環素之單醋酸纖維素奈 例8)之SEM圖像。 β 圖4a為含有〇〇/〇多西環素之三醋酸纖維素(TAC)奈米纖維膜(比 較例D)之粒徑分佈。 、 圖4b為含有〇%多西環素之三醋酸纖維素奈米纖維膜(比較例 D)之SEM圖像。 圖5a為含有0.02%多西環素之三醋酸纖維素奈米纖維膜(實施 例9)之粒徑分佈。 圖5b為含有0.02%多西環素之三醋酸纖維素奈米纖維膜(實施 例9)之SEM圖像。 圖6a為含有0.04%多西環素之-例10)之粒徑分佈。 三醋酸纖維素奈米纖維膜(實施 圖6b為含有0.04%多西環素夂 例10)之SEM圖像。 圖7為含有0.08%多西環素之 彡 醋酸纖維素奈米纖維膜(實施 赠酸纖維素奈米纖維膜(實施例 20 201016921 11) 之粒徑分佈。 圖8為含有0.10%多西環素之三醋酸纖維素奈米纖維膜(實施例 12) 之粒徑分佈。 圖9a為含有0%多西環素之三醋酸纖維素奈米纖維膜(比較例 5 D)之定性抑菌測試結果。 圖9b為含有0.02%多西環素之三醋酸纖維素奈米纖維膜(實施 例9)之定性抑菌測試結果。 Θ 【主要元件符號說明】 1〇 無 28The multi-display of ❿, the cellulose acetate electrospinning containing 嶋 to 喔 organism: knows that tetracycline compound or its derivative is added. Furthermore, since the tetracycline compound or the material itself has a batch phase energy, the nanofiber film formed by the above-mentioned bright film can have excellent antibacterial property at the same time. According to the technique of the present invention, the upper frequency is implemented. _, so that the general knowledge of the field of n can understand the content of the second case of this case, and use the limit (4), so the improvement or repair of the invention (10) and the spirit of the present invention should still be covered by the present invention. Fan is inside. BRIEF DESCRIPTION OF THE DRAWINGS Fig. la is a monoacetate (CA) nanofiber membrane containing 10% doxycycline (10). 26 15 201016921 Example C) Particle size distribution diagram lb c) Leg ίί Cyclocycline single with _ her_film shouting example e 10 15 ❹ Example η map = cloth with 〇. 〇 2% doxycycline single-acid acid cellulose nanofiber canister example == 瞧乡神细The __mei shaft (implementing Fig. 3a is a single vinegar example 8 containing 0.04% doxycycline). The SEM image of the early rice-transfer film (implementation Fig. 3b is a monoacetate cellulose containing 0.04% of cilostatin). β Figure 4a shows the particle size distribution of a cellulose triacetate (TAC) nanofiber membrane containing 〇〇/〇 doxycycline (Comparative Example D). Figure 4b is an SEM image of a cellulose triacetate nanofiber membrane containing 〇% doxycycline (Comparative Example D). Fig. 5a is a particle size distribution of a cellulose triacetate nanofiber membrane containing 0.02% doxycycline (Example 9). Figure 5b is an SEM image of a cellulose triacetate nanofiber membrane containing 0.02% doxycycline (Example 9). Figure 6a is a particle size distribution of Example 10) containing 0.04% doxycycline. An SEM image of a cellulose triacetate nanofiber membrane (Fig. 6b is a sample containing 0.04% doxycycline Example 10). Fig. 7 is a particle size distribution of a cellulose acetate nanofiber membrane containing 0.08% of doxycycline (implementing a cellulose acetate nanofiber membrane (Example 20 201016921 11). Fig. 8 is a mixture containing 0.10% of doxycycline. The particle size distribution of the cellulose triacetate nanofiber membrane (Example 12). Figure 9a is a qualitative bacteriostatic test of a cellulose triacetate nanofiber membrane containing 0% doxycycline (Comparative Example 5 D). Results Fig. 9b shows the results of qualitative bacteriostatic test of cellulose triacetate nanofiber membrane containing 0.02% doxycycline (Example 9). Θ [Explanation of main components] 1〇28

Claims (1)

201016921 七、申請專利範圍: 1. 一種用於製造奈米纖維膜材之靜電紡絲組成物,其包含: A)含有醋酸纖維素與溶劑之均勻溶液,其中,以溶液的重量為基準, 該醋酸纖維素的含量為〇.〇1至20重量%,及該溶劑選自群組包含三 5 氣曱烧、一氣甲烧、二曱基亞石風、二甲基曱蕴胺、乙醇、四氫Π夫n南、 醋酸及丙_或上述至少二者的組合, Β)以上述均勻溶液的重量為基準,〇 〇1至1〇〇重量%之式①四環素 φ 化合物及其衍生物,201016921 VII. Patent application scope: 1. An electrospinning composition for manufacturing a nanofiber membrane, comprising: A) a homogeneous solution containing cellulose acetate and a solvent, wherein, based on the weight of the solution, The content of cellulose acetate is 〇.〇1 to 20% by weight, and the solvent is selected from the group consisting of three 5 gas smoldering, one gas smoldering, diterpene sulphur, dimethyl sulphamine, ethanol, and four. Hydrogen oxime n, acetic acid and propylene _ or a combination of at least two of the above, Β) based on the weight of the above homogeneous solution, 〇〇1 to 1% by weight of the tetracycline φ compound of formula 1 and its derivatives, 29 201016921 含量範圍為20至80重量%,以醋酸纖維素重量為基準。 6. 根據申請專利範圍第5項之組成物’其中該醋酸&quot;纖維素中的乙酸 基含量範圍為30至70重量%,以醋酸纖維素重量為基準'。、_ 7. 根據申請專利範圍第6項之組成物,其中該醋酸纖&quot;維素中的乙酿 5 基含量為40至55重量%,以醋酸纖維素重量為基準。 8. 根據申請專利範圍第1項之組成物,其中,以均勻溶液的重量為 基準’該醋酸纖維素的含量為0.01至15重量。/。。 里^ φ 9.根據申請專利範圍第8項之組成物,其中,以均勻溶液的舌旦么 基準,該醋酸纖維素的含量為0.01至8重量。/。。 10 10.根據申請專利範圍第1項之組成物’其中式(I)四環素化合物中, R~i為Η,R_2及&amp;各自獨立地為Η及CH3,R4及R5為cpj3。 11. 根據申清專利轉圍第1項之組成物’其中四環素化合物及盆衍生 物為多西環素(Doxycycline)、四環黴素(Tetracycline)、土黴素 (Oxytetracycline)、美諾環素(Minocycline)、氯四環素 15 (Chlortetracycline)、地美環素(Demecl〇cycline)或替加環素 , (Tigecycline)。 12. 根據申請專利範圍第η項之組成物,其中式①四環素化合物為 多西環素。 13. 根據申請專利範圍第1項之組成物,其中,以醋酸纖維素均勻溶 20 液的重量為基準’式(I)四環素化合物及其衍生物的含量為0.01至 0.20重量%。 14. 根據申請專利範圍第13項之組成物,其中,以醋酸纖維素均勻 溶液的重量為基準’式(I)四環素化合物及其衍生物的含量為0.02至 0.12重量%。 30 201016921 l5.根據申請專利範圍第14項之組成物,其中,以醋酸纖維素均句 溶液的重量絲準,式(1)四環素化合物及其衍生物的含量為_至 0.10重量%。 16·根據申請專利範圍第!至15項中任一項之組成物,其中四環素 5化合物及其衍生物進一步具有抗菌功能。 ” Π.根據巾請專利範15第丨項之組成物,其中溶劑為二氯甲烧與二甲 基亞礙之共溶劑或醋酸與丙明的共溶劑。 ❹18.根據申請專利範圍第Π項之組成物,其中該共溶劑中的溶劑成 份重量比例為1 : 29至29 : 1。 1〇 19·根據申請專利範圍第18項之組成物,其中該共溶劑中的溶劑成 份重量比例為1 : 10至20 : !。 20. 根據申請專利範圍第19項之組成物,其中該共溶劑中的溶劑成 份重量比例為1 : 1至18 : 1。 21. 根據申睛專利範圍第2〇項之組成物,其中該共溶劑為含有二氯 ”甲^與二甲基亞颯之重量比例為1 : i的共溶劑或含有醋酸與丙嗣之 _ 重里比例為8 : 2的共溶劑。 22. 根據申請專利範圍第i項之組成物,其具有導電度介於1〇_3至 10_7 1/Ω 之間。 23. —種改善醋酸纖維素奈米纖維之導電度及細度之方法,其步驟包 20 含: A)將0.01至2〇重1%之醋酸纖維素高分子加入一共溶劑中,以配製 -含有醋酸纖維素高分子溶液,其巾共賴由選自包含二氯曱烧、 二曱基亞颯、醋酸及丙酮之群組中的二種溶劑所構成,其重量比例 為 1 · 29 至 29 : 1 ; 201016921 B)將0.01至uo重量%四環素化合物添加 液中,以製得具有導電度介於㈤至1(r7 =配I如分子溶 分子溶液,其中四環素化合物為_之四騎雜纖維素高 〇Η 〇 ΟΗ 〇 _ 、J 王初.29 201016921 The content ranges from 20 to 80% by weight based on the weight of cellulose acetate. 6. The composition according to item 5 of the patent application' wherein the acetic acid content in the cellulose ranges from 30 to 70% by weight based on the weight of the cellulose acetate. 7. The composition according to item 6 of the patent application, wherein the content of the ethyl acetate in the cellulose acetate is 40 to 55% by weight based on the weight of the cellulose acetate. 8. The composition according to claim 1, wherein the cellulose acetate is present in an amount of from 0.01 to 15% by weight based on the weight of the homogeneous solution. /. . The composition of the eighth aspect of the patent application, wherein the cellulose acetate is present in an amount of from 0.01 to 8 by weight based on the basis of the uniform solution. /. . 10 10. The composition according to the first aspect of the patent application' wherein, in the tetracycline compound of the formula (I), R~i is Η, R_2 and & are each independently Η and CH3, and R4 and R5 are cpj3. 11. According to the composition of the patent clearing of the first paragraph of the patent, 'the tetracycline compound and the potted derivatives are Doxycycline, Tetracycline, Oxytetracycline, and Menocycline. (Minocycline), Chlortetracycline, Demecl〇cycline or Tigecycline. 12. The composition according to item η of the patent application, wherein the tetracycline compound of formula 1 is doxycycline. 13. The composition according to the first aspect of the invention, wherein the content of the tetracycline compound of the formula (I) and the derivative thereof is from 0.01 to 0.20% by weight based on the weight of the cellulose acetate homogeneous solution. 14. The composition according to claim 13 wherein the content of the tetracycline compound and the derivative thereof of the formula (I) is from 0.02 to 0.12% by weight based on the weight of the cellulose acetate homogeneous solution. 30. The composition of claim 14, wherein the content of the tetracycline compound of the formula (1) and the derivative thereof is from _ to 0.10% by weight based on the weight of the cellulose acetate homologous solution. 16· According to the scope of the patent application! The composition of any one of the items 15, wherein the tetracycline 5 compound and the derivative thereof further have an antibacterial function. Π. According to the composition of the scope of the patent, the solvent is a co-solvent of methylene chloride and dimethyl sulfoxide or a co-solvent of acetic acid and propylamine. ❹ 18. According to the scope of the patent application a composition wherein the solvent component in the cosolvent has a weight ratio of 1:29 to 29:1. 1〇19. The composition according to claim 18, wherein the solvent component in the cosolvent has a weight ratio of 1 : 10 to 20 : ! 20. The composition according to claim 19, wherein the solvent component in the cosolvent has a weight ratio of 1:1 to 18: 1. 21. According to the scope of claim 2 The composition, wherein the cosolvent is a cosolvent having a weight ratio of dichloro"methyl dimethyl hydrazine to dimethyl hydrazine of 1: i or a cosolvent having a ratio of acetic acid to propylene glycol of 8:2. 22. The composition according to item i of the patent application has a conductivity of between 1 〇 3 and 10 _ 7 1 / Ω. 23. A method for improving the conductivity and fineness of cellulose acetate nanofibers, wherein the package 20 comprises: A) adding 0.01 to 2% by weight of 1% cellulose acetate polymer to a cosolvent to prepare - The invention comprises a cellulose acetate polymer solution, wherein the towel is composed of two solvents selected from the group consisting of dichloropyrene, dimercaptopurine, acetic acid and acetone, and the weight ratio thereof is from 1 to 29 to 29 : 1 ; 201016921 B) 0.01 to uo weight% tetracycline compound addition liquid to obtain a conductivity of (5) to 1 (r7 = with I such as molecularly soluble molecular solution, wherein tetracycline compound is _ four riding fiber Su Gaoqi 〇ΟΗ 〇 _, J Wang Chu. νη2 Rj R2 R3 ❹ (I) 式中, &amp;為11或(:1_6烷基, R2及R3各自獨立地為H、0H或C16烷基, ^4及Rs各自獨立地為Η或Cm烷基, 鲁 C)將^聰得的高分子溶賴過包含紡嘴與電極之靜電 置’其操作電壓範圍介於5kV至紐V之間,以紡出具有直= 50奈米至500奈米之間的奈米纖維。 、 根據申請專利範圍第μ項之方法,其中醋酸纖維素選自單 纖維素或三醋酸纖維素。 _ 25. 根據申請專利範_ 23項之方法,其中共溶劑為含有二氯甲燒 與一曱基亞颯的共溶劑或含有醋酸與丙酮的共溶劑。 26. 根據申請專利範圍第23項之方法,其中四環素化合物及其衍生 物為多西環素、四環黴素、土黴素、美諾環素、氯四環素、地美環 素或替加環素。 27. 根據申請專利範圍第26項之方法,其中四環素化合物為多西環 素。 32 201016921 28. —種醋酸纖維素奈米纖維 1至 22項中任-項之靜電纺絲組成申請專利範圍第 29. 根據申請專利範圍第Μ項之膜材,其 至27項中任一項之方法製得。 像甲明專利犯圍弟23 30. —種具有抗菌性之醋酸纖維辛奋 直刹n i 纖維騎,其特徵在於由申請 專利範财1至22項巾任—項植成物所製得。 參 3L根據申請專利範圍第30項之膜材,其係根據申請專利範圍第23 至27項中任一項之方法製得。 ❹ 33Νη2 Rj R2 R3 ❹ (I) wherein &amp; is 11 or (:1_6 alkyl, R2 and R3 are each independently H, 0H or C16 alkyl, and ^4 and Rs are each independently Η or Cm alkyl , Lu C) will dissolve the polymer of ^Cong to the electrostatic containing the nozzle and the electrode. The operating voltage range is from 5kV to NZV, and the spinning has a straightness of 50nm to 500nm. Intercrystalline fiber. According to the method of claim 5, wherein the cellulose acetate is selected from the group consisting of monocellulose or cellulose triacetate. </ RTI> 25. The method according to claim 23, wherein the cosolvent is a cosolvent containing methylene chloride and monodecyl hydrazine or a cosolvent containing acetic acid and acetone. 26. The method according to claim 23, wherein the tetracycline compound and its derivative are doxycycline, tetracycline, oxytetracycline, minocycline, chlorotetracycline, dimecycline or tigecycline Prime. 27. The method according to claim 26, wherein the tetracycline compound is doxycycline. s. The method is made. Like the patent of the Jiaming squad 23 30. A kind of antibacterial acetate fiber singular direct brake n i fiber riding, which is characterized by the application of patent Fancai 1 to 22 towel--plants. </ RTI> </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; ❹ 33
TW97141495A 2008-10-29 2008-10-29 Electrospinning compositions for the preparation of nanofibers and the applications thereof TWI376440B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW97141495A TWI376440B (en) 2008-10-29 2008-10-29 Electrospinning compositions for the preparation of nanofibers and the applications thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW97141495A TWI376440B (en) 2008-10-29 2008-10-29 Electrospinning compositions for the preparation of nanofibers and the applications thereof

Publications (2)

Publication Number Publication Date
TW201016921A true TW201016921A (en) 2010-05-01
TWI376440B TWI376440B (en) 2012-11-11

Family

ID=44830578

Family Applications (1)

Application Number Title Priority Date Filing Date
TW97141495A TWI376440B (en) 2008-10-29 2008-10-29 Electrospinning compositions for the preparation of nanofibers and the applications thereof

Country Status (1)

Country Link
TW (1) TWI376440B (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012141938A1 (en) * 2011-04-11 2012-10-18 University Of Massachusetts Medical School Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds
TWI453312B (en) * 2011-02-18 2014-09-21 Univ Kun Shan Preparation the polymer fiber for solar cells and light emitting device by directly electrospinning technique
US9761354B2 (en) 2013-04-18 2017-09-12 Industrial Technology Research Institute Method of manufacturing a nano metal wire
US10798966B2 (en) 2014-01-21 2020-10-13 British American Tobacco (Investments) Limited Filter materials and filters made therefrom
CN113703086A (en) * 2021-09-09 2021-11-26 武汉华星光电半导体显示技术有限公司 Polarizer, manufacturing method thereof and display device

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI473646B (en) * 2013-01-15 2015-02-21 Univ Nat Yunlin Sci & Tech Fibrous membrane and a method for using the fibrous membrane for wastewater treatment
US11199476B2 (en) * 2017-01-13 2021-12-14 Luna Innovations Incorporated Dissolvable nanofiber materials and specimen recovery kits including the same for high efficiency specimen recovery
TWI738192B (en) * 2020-01-22 2021-09-01 國立宜蘭大學 Nanofiber and its preparation method and use

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI453312B (en) * 2011-02-18 2014-09-21 Univ Kun Shan Preparation the polymer fiber for solar cells and light emitting device by directly electrospinning technique
WO2012141938A1 (en) * 2011-04-11 2012-10-18 University Of Massachusetts Medical School Chemically modified cellulose fibrous meshes for use as tissue engineering scaffolds
US9761354B2 (en) 2013-04-18 2017-09-12 Industrial Technology Research Institute Method of manufacturing a nano metal wire
US10798966B2 (en) 2014-01-21 2020-10-13 British American Tobacco (Investments) Limited Filter materials and filters made therefrom
CN113703086A (en) * 2021-09-09 2021-11-26 武汉华星光电半导体显示技术有限公司 Polarizer, manufacturing method thereof and display device
CN113703086B (en) * 2021-09-09 2022-07-26 武汉华星光电半导体显示技术有限公司 Polarizer, manufacturing method thereof and display device

Also Published As

Publication number Publication date
TWI376440B (en) 2012-11-11

Similar Documents

Publication Publication Date Title
Hajikhani et al. Fabrication and characterization of mucoadhesive bioplastic patch via coaxial polylactic acid (PLA) based electrospun nanofibers with antimicrobial and wound healing application
TW201016921A (en) Electrospinning compositions for the preparation of nanofibers and the applications thereof
He et al. Fabrication of metronidazole loaded poly (ε-caprolactone)/zein core/shell nanofiber membranes via coaxial electrospinning for guided tissue regeneration
Mahmoudi et al. On the biological performance of graphene oxide-modified chitosan/polyvinyl pyrrolidone nanocomposite membranes: In vitro and in vivo effects of graphene oxide
Ziyadi et al. An investigation of factors affecting the electrospinning of poly (vinyl alcohol)/kefiran composite nanofibers
Shen et al. Application of solution blow spinning to rapidly fabricate natamycin-loaded gelatin/zein/polyurethane antimicrobial nanofibers for food packaging
He et al. Electrospinning polyvinylidene fluoride fibrous membranes containing anti-bacterial drugs used as wound dressing
Shen et al. Chitosan/PCL nanofibrous films developed by SBS to encapsulate thymol/HPβCD inclusion complexes for fruit packaging
Chen et al. Hierarchical porous nanofibers containing thymol/beta-cyclodextrin: Physico-chemical characterization and potential biomedical applications
Wei et al. Magnetic biodegradable Fe3O4/CS/PVA nanofibrous membranes for bone regeneration
Han et al. Electrospun shikonin-loaded PCL/PTMC composite fiber mats with potential biomedical applications
Zhang et al. Superior water stability and antimicrobial activity of electrospun gluten nanofibrous films incorporated with glycerol monolaurate
CN104761737B (en) A kind of method that method of electrostatic spinning prepares collagen/stannic oxide/graphene nano composite fiber membrane
Chen et al. Preparation and application of chitosan-based medical electrospun nanofibers
Maharjan et al. In-situ synthesis of AgNPs in the natural/synthetic hybrid nanofibrous scaffolds: Fabrication, characterization and antimicrobial activities
CN108714234A (en) Biodegradable graphene oxide composite cellulosic membrane and its preparation method and application
Wang et al. Kinetics and antioxidant capacity of proanthocyanidins encapsulated in zein electrospun fibers by cyclic voltammetry
CN106149203B (en) A kind of medicament-carrying nano-fiber membrane and its application
Zhang et al. Fabrication of green poly (vinyl alcohol) nanofibers using natural deep eutectic solvent for fast-dissolving drug delivery
JP2011167237A (en) Bio-applicable material
CN110292652A (en) Mercaptophenyl boronic acid activates gold nano grain, preparation method and application
Karuppannan et al. Fabrication of progesterone-loaded nanofibers for the drug delivery applications in bovine
Amiri et al. Optimization of chitosan-gelatin nanofibers production: Investigating the effect of solution properties and working parameters on fibers diameter
Lu et al. Nanocomposites prepared by electrohydrodynamics and their drug release properties
Zhao et al. Flexible, robust and self-peeling PLA/AgNWs nanofiber membranes with photothermally antibacterial properties for wound dressing